Integrated management of cardio-renal-metabolic syndrome: Egyptian multi-society expert consensus and clinical practice algorithm

Clicks: 3
ID: 327557
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #290 of 291 articles by views in European heart journal supplements : journal of the European Society of Cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 291 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Cardio-Renal-Metabolic (CRM) syndrome represents a major public health challenge in Egypt, contributing significantly to local morbidity, mortality, and healthcare expenditure. Existing international management guidelines lack localized, structured frameworks suitable for deployment within the Egyptian healthcare landscape. Methods A modified executive consensus process with binary voting was conducted among ten leading Egyptian experts representing the Cardiovascular Research, Education & Prevention Foundation (CVREP), the Egyptian Society of Diabetes and Lipidology (ESDL), and the Egyptian Society of Nephrology and Transplantation (ESNT). A predefined agreement threshold was set at 85%. The panel evaluated 10 core CRM consensus domains covering disease taxonomy, screening, and stage-specific management pathways. Results Unanimous agreement (100% consensus, 10/10 voters) was achieved across all 10 clinical domains during the initial voting round; consequently, additional rounds were not required. The panel translated these consensus domains into 10 clinical recommendation statements and synthesized them into a centralized, actionable healthcare algorithm tailored for both primary care and specialty settings. Key directives mandate systemic biological screening—utilizing estimated Glomerular Filtration Rate (eGFR) and Urinary Albumin-to-Creatinine Ratio (UACR)—alongside Social Determinants of Health (SDOH) assessments. The consensus formalizes the prioritization of cardioprotective and renoprotective guideline-directed medical therapies (GDMT), establishing dedicated implementation rules for Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors and Glucagon-Like Peptide-1 (GLP-1) receptor agonists. Conclusions This Egyptian Multi-Society Consensus provides a practical, evidence-aligned framework designed to dismantle clinical siloing in the management of Cardio-Renal-Metabolic syndrome. By nationwide distribution of a unified algorithm to both GPs and referral specialists, paired with comprehensive educational workshops, public awareness campaigns, and standardized laboratory testing protocols, this initiative establishes a seamless, shared care model across Egyptian healthcare sectors. Systematically auditing provider adoption and diagnostic completion rates will ensure that this framework delivers measurable improvements in early detection, timely GDMT optimization, and long-term patient outcomes.
Reference Key
openalex_W7207786401 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mohamed Sobhy, Khalifa Abdallah, Ayman Refaie, Amin Fouad, Magdy Elsharkawy, Ahmed Fathy El Koraey, Mohamed Sadaka, ElSayed Farag, Fawzy ElMessallamy, Ibrahim Elebrashy
Journal European heart journal supplements : journal of the European Society of Cardiology
Year 2026
DOI
10.1093/eurheartjsupp/suag109.004
URL
https://doi.org/10.1093/eurheartjsupp/suag109.004
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.